28797885 34108219 31322581 31864390 30423399 30571694 31085616 30578345 28443359 30590647 32714591 33007689 33720852 31292254 30261006 - Search Results

Year	Number of Results
2017	2
2018	6
2019	7
2020	1
2021	2
2023	0

1

Mitophagy in neurodegenerative diseases.

Rodolfo C, Campello S, Cecconi F. Rodolfo C, et al. Neurochem Int. 2018 Jul;117:156-166. doi: 10.1016/j.neuint.2017.08.004. Epub 2017 Aug 8. Neurochem Int. 2018. PMID: 28797885 Review.

2

Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor.

Cornblath EJ, Li HL, Changolkar L, Zhang B, Brown HJ, Gathagan RJ, Olufemi MF, Trojanowski JQ, Bassett DS, Lee VMY, Henderson MX. Cornblath EJ, et al. Sci Adv. 2021 Jun 9;7(24):eabg6677. doi: 10.1126/sciadv.abg6677. Print 2021 Jun. Sci Adv. 2021. PMID: 34108219 Free PMC article.

3

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?

Loeffler DA, Aasly JO, LeWitt PA, Coffey MP. Loeffler DA, et al. J Parkinsons Dis. 2019;9(3):467-488. doi: 10.3233/JPD-191630. J Parkinsons Dis. 2019. PMID: 31322581 Free PMC article. Review.

4

LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.

Berwick DC, Heaton GR, Azeggagh S, Harvey K. Berwick DC, et al. Mol Neurodegener. 2019 Dec 21;14(1):49. doi: 10.1186/s13024-019-0344-2. Mol Neurodegener. 2019. PMID: 31864390 Free PMC article. Review.

5

Phosphorylation of serine 305 in tau inhibits aggregation.

Strang KH, Sorrentino ZA, Riffe CJ, Gorion KM, Vijayaraghavan N, Golde TE, Giasson BI. Strang KH, et al. Neurosci Lett. 2019 Jan 23;692:187-192. doi: 10.1016/j.neulet.2018.11.011. Epub 2018 Nov 10. Neurosci Lett. 2019. PMID: 30423399 Free PMC article.

6

Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics.

Bardai FH, Ordonez DG, Bailey RM, Hamm M, Lewis J, Feany MB. Bardai FH, et al. PLoS Biol. 2018 Dec 20;16(12):e2006265. doi: 10.1371/journal.pbio.2006265. eCollection 2018 Dec. PLoS Biol. 2018. PMID: 30571694 Free PMC article.

7

LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?

Outeiro TF, Harvey K, Dominguez-Meijide A, Gerhardt E. Outeiro TF, et al. Biochem Soc Trans. 2019 Jun 28;47(3):827-838. doi: 10.1042/BST20180466. Epub 2019 May 13. Biochem Soc Trans. 2019. PMID: 31085616 Review.

8

The role of LRRK2 in cell signalling.

Harvey K, Outeiro TF. Harvey K, et al. Biochem Soc Trans. 2019 Feb 28;47(1):197-207. doi: 10.1042/BST20180464. Epub 2018 Dec 21. Biochem Soc Trans. 2019. PMID: 30578345 Review.

9

Targeting LRRK2 in Parkinson's disease: an update on recent developments.

Chan SL, Tan EK. Chan SL, et al. Expert Opin Ther Targets. 2017 Jun;21(6):601-610. doi: 10.1080/14728222.2017.1323881. Epub 2017 May 15. Expert Opin Ther Targets. 2017. PMID: 28443359 Review.

10

Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport.

Butler VJ, Salazar DA, Soriano-Castell D, Alves-Ferreira M, Dennissen FJA, Vohra M, Oses-Prieto JA, Li KH, Wang AL, Jing B, Li B, Groisman A, Gutierrez E, Mooney S, Burlingame AL, Ashrafi K, Mandelkow EM, Encalada SE, Kao AW. Butler VJ, et al. Hum Mol Genet. 2019 May 1;28(9):1498-1514. doi: 10.1093/hmg/ddy442. Hum Mol Genet. 2019. PMID: 30590647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results